MedPath

Disturbed ion homeostasis in hereditary hemolytic anaemia

Completed
Conditions
bloedarmoede
heriditary hemolytic anaemia
10038158
Registration Number
NL-OMON43679
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
140
Inclusion Criteria

Patient suffering from HHA, based on the following criteria;
• A proposed RBC ion homeostasis disturbance due to a primary cause; membrane defects (spherocytosis, stomatocytosis) of the red blood cell (previously diagnosed by with a decreased EImax detected by osmotic gradient ektacytometry, or altered osmotic fragility, or altered EMA-binding test, or mutations found in SPTA1, SPTB, SLC4A1, ANK1, EPB41, EPB42, PIEZO1, RHAG.
• A proposed RBC ion homeostasis disturbance due to a secondary cause; hemoglobinopathies (sickle cell anaemia, thallasemia) or enzymopathies of the red cell (previously diagnosed by detection of HbA2, HbF, HbS, HbE, HbD, HbC by electrophoresis, or decreased enzyme activity in red blood cell enzymes (PK, HK, G6PD, GPI, F-ALD, TPI, PGK, BPGM, GSR), or mutations found in HBA1, HBA2, HBB, PFKM, PGK1, G6PD, GPI1, HK1, PKLR)
• Hemolytic anemia due to an unknown cause; patients previously screened for iron deficiency anaemia and other forms of nutritional deficiency anaemia, anaemia due to chronic illnesses or infection, membrane defects of the red cell, hemoglobinopathies and/or enzymopathies, without the detection of a (molecular) cause for the haemolytic anaemia.
- Biological parent of a patient suffering from haemolytic anaemia due to an unknown cause

Exclusion Criteria

- Transfusion (erythrocyte concentrate) received in the last 90 days
- For children: body weight <= 18kg
- Age <= 3 years

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath